Back to search

Article

Effect of disclosing a polygenic risk score for coronary heart disease on adverse cardiovascular events: 10-year follow-up of the MI-GENES randomized clinical trial

2024-07-19

Abstract excerpt

<h4>Background</h4> The MI-GENES clinical trial ( NCT01936675 ), in which participants at intermediate risk of coronary heart disease (CHD) were randomized to receive a Framingham risk score (FRS g , n=103), or an integrated risk score (IRS g , n=104) that additionally included a polygenic risk score (PRS), demonstrated that after 6 months, participants randomized to IRS g had higher statin initiation and low...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c44b9543-de24-5418-9e4e-5ceee0d81fd2
DOI
10.1101/2024.07.19.24310709
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Effect of disclosing a polygenic risk score for coronary heart disease on adverse cardiovascular events: 10-year follow-up of the MI-GENES randomized clinical trialDOI 10.1101/2024.07.19.24310709
Select a neighboring publication to make it the new centre.